Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04011176 · ClinicalTrials.gov registry record · NA

Microcurrent Treatment for Chronic Debilitating Pain

A NA study, sponsored by Paul Crawford.

Completed
Registry status
NA
Development phase
200
Enrollment target

NCT04011176 is a NA study that has completed, run by Paul Crawford. The registered enrollment target is 200 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04011176, a NA study, has completed, sponsored by Paul Crawford.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target

Study Summary

To compare the efficacy of standard pain treatment and placebo (a microcurrent faux treatment) as opposed to standard pain treatment and microcurrent therapy in any primary care patients over a three month period.

Interventions

  • PROCEDURE Standard treatment + placebo
  • PROCEDURE Standard treatment + Microcurrent Therapy

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2019-12-09
Est. Completion 2022-06-01
Phase NA

Sponsor

Paul Crawford

6 total trials

What the Registry Record Tells You About NCT04011176

The ClinicalTrials.gov registry entry for NCT04011176 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Paul Crawford, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Standard treatment + placebo is the first listed.

NCT04011176 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04011176 about?

NCT04011176 is a clinical study titled "Microcurrent Treatment for Chronic Debilitating Pain". To compare the efficacy of standard pain treatment and placebo (a microcurrent faux treatment) as opposed to standard pain treatment and microcurrent therapy in any primary care patients over a three month period.

What is the current status of trial NCT04011176?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2019-12-09. Estimated completion is 2022-06-01.

What interventions are being tested in trial NCT04011176?

The interventions under investigation include: Standard treatment + placebo (PROCEDURE), Standard treatment + Microcurrent Therapy (PROCEDURE).

Who is sponsoring clinical trial NCT04011176?

This trial is sponsored by Paul Crawford, which has 6 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.